This Independence Day, we celebrate the innovation, perseverance, and spirit that has helped shape this nation. We hope you all have a spark-tacular and a safe holiday! #4thofJuly #IndependenceDay
Halloran Consulting Group, Inc.
Business Consulting and Services
Boston, Massachusetts 7,308 followers
Halloran is a life science consulting firm providing strategic regulatory, quality, and clinical insights.
About us
Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve.
- Website
-
http://www.hallorancg.com
External link for Halloran Consulting Group, Inc.
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 1998
- Specialties
- Regulatory Strategy/Submissions, Quality Systems, Clinical Development, Due Diligence, TMF, Organizational Development, Program Management, Gap Analysis, Clinical Finance, Change Management, Vendor Management, Inspection Readiness, Training, Technology Adoption, Clinical Trials, Clinical Research, Virtual Clinical Trials, Decentralized Clinical Trials, Organizational Solutions, Data Management, Technology Implementation, Strategy Management, and Program Leadership
Locations
-
Primary
22 Thomson Pl
Boston, Massachusetts 02210, US
-
3040 Science Park Rd
San Diego, California 92121, US
Employees at Halloran Consulting Group, Inc.
Updates
-
Before the Orphan Drug Act (ODA) was signed into law, the FDA approved approximately two drugs per year for rare diseases. Now, 40 years after the ODA, hundreds of orphan drugs have been approved for use in the many diseases and conditions that are considered rare. What’s in store for the next 40 years? Read Gail Winslow, MS, APR take on insights shared during the panel, “Sustainability of Rare Disease Drug Development,” at #DIA2024 https://hubs.la/Q02F7rN60 #orphandisease #raredisease #orphandrugact #FDA #acceleratedapproval
-
Join Consulting Magazine for an insightful panel discussion featuring Halloran's COO, Brittany Sipos, where operational leaders from professional services firms will delve into the importance of agility, flexibility, and efficiency in driving innovation and growth. Discover how these qualities enhance creativity, productivity, and expertise, beyond just cutting costs. Don't miss this opportunity to gain valuable insights from a recent C-level survey and learn about innovative strategies that elevate performance in professional services. 📅 Thursday, July 11, 2024 | 11am EST 🔗 https://hubs.la/Q02CKtwj0 #ProfessionalServices #Innovation #OperationalEfficiency #Technology #AI
Balancing Growth Objectives with Operational Efficiency: Unleashing Partner Productivity
consultingmag.com
-
Last year, the FDA released, “A Risk-Based Approach to Monitoring of Clinical Investigations, Questions and Answers, Guidance for Industry.” This guidance is noted to expand on the prior guidance released over a decade ago. Our team has seen an interest from our life science community in our review of the guidance’s four key themes: questions concerning risk, developing your monitoring strategy, risk assessment as a continuous process, and the importance of a root cause analysis. https://hubs.la/Q02CDJsg0 If you are interested in further unpacking this guidance or have questions about your monitoring approach, we’re ready to start the conversation. #FDAGuidance #ClinicalTrials #ClinicalInvestigations #RiskBasedMonitoring #QMS #QualityManagement
Risk-Based Approach to Monitoring of Clinical Investigations
https://www.hallorancg.com
-
Halloran is #hiring! Join our team! Click here to discover our available positions: https://hubs.la/Q02CKvcf0 #SalesJobs #ConsultingJobs #LifeScienceJobs #RegulatoryJobs
-
Are you sponsoring a clinical trial, wondering how to develop an Informed Consent Form? You’re not alone. In this on-demand webinar, our team reviews the principles and requirements of informed consent and shares common challenges and recommendations in the landscape of increasingly complex clinical studies. Ready? Watch our webinar and walk away with actionable steps to improve the clarity, simplicity, and transparency of Informed Consent Forms to improve participant experience and understanding. https://hubs.la/Q02CDy5z0 #ClinicalOperations #InformedConsent #FDAGuidance #ClinicalTrials
Implications of FDA's Final Guidance on Informed Consent
https://www.hallorancg.com
-
TOMORROW! Join our webinar, "Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within". Our expert panel from The Leadership Edge, Halloran Consulting Group, and Inozyme Pharmaceuticals will share their insights for leading your team through development. Register now! https://hubs.la/Q02ClRCj0 #Biotech #Pharma #Webinar #TalentDevelopment #Leadership #LifeSciences
-
Leaders at biopharma companies often ask us, “what is a culture of quality and how do you build it?” and we encourage those leaders to consider the opportunity because the payoff is significant. Sheila Gwizdak identifies the key elements in a culture of quality, how to enable a culture of quality, and the benefits and impact. Whether you’re a CMO or an acting executive of your company, you have an opportunity to help shape your corporate culture for the better! Contact us to start the discussion. https://hubs.la/Q02CDrkN0 #CultureOfQuality #LifeSciences #BiopharmaLeadership #OrganizationalTransformation
Establishing a Culture of Quality: What Every CMO Should Know | Halloran Consulting Group
https://www.hallorancg.com
-
As #DIA2024 wraps up, we wanted to share a big thank you to everyone who visited our booth or met with us during the week! Our team had an incredible time connecting with industry leaders, catching up with old friends, and making some time for team bonding. We're excited to continue these conversations and share our key takeaways through upcoming blogs and thought leadership. Stay tuned!
-
As we celebrate Juneteenth, we honor the resilience, strength, and contributions of Black Americans to our nation's history. In the life sciences industry, diversity fuels innovation and progress. We remain committed to fostering an inclusive environment where every voice is heard and valued, driving breakthroughs that improve health for all. #HappyJuneteenth from Halloran!